Ignite Creation Date:
2024-05-06 @ 5:27 PM
Last Modification Date:
2024-10-26 @ 2:29 PM
Study NCT ID:
NCT05319587
Status:
RECRUITING
Last Update Posted:
2023-11-18
First Post:
2022-02-22
Brief Title:
Study of Liposomal Annamycin in Combination With Cytarabine for the Treatment of Subjects With Acute Myeloid Leukemia AML
Sponsor:
Moleculin Biotech Inc
Organization:
Moleculin Biotech Inc
Organization Data
Organization:
Moleculin Biotech Inc
Class:
INDUSTRY
Study ID:
MB-106
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Moleculin Biotech Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None